FDA Approvals in Oncology: July-September 2025
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
Author:
Cancer Research Catalyst Staff
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
The 2025 AACR Journal Awards recognized outstanding researchers whose studies made in a significant impact in their respective domains.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
For June 2025, the editors of AACR's journals highlighted studies on pancreatic cancer interception, breast cancer risk prediction, and...
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data...
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research,...